sj-pdf-2-cep-10.1177_03331024211053571 - Supplemental material for Erenumab versus topiramate for the prevention of migraine ��� a randomised, double-blind, active-controlled phase 4 trial

Supplemental material, sj-pdf-2-cep-10.1177_03331024211053571 for Erenumab versus topiramate for the prevention of migraine ��� a randomised, double-blind, active-controlled phase 4 trial by Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Axel Heinze, Jan Klatt, Shihua Wen, Peggy Hours-Zesiger, Jacqueline Nickisch, Christian Sieder, Christian Hentschke and Monika Maier-Peuschel in Cephalalgia